EUVIMEDEUVIMED entdecken
Open Access

Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell–Intrinsic Immune Tolerance

Taylor K Watson iD, Aaron B I Rosen iD, Travis Drow iD, Jacob A Medjo iD, Matthew A MacQuivey, Yan Ge iD, H Denny Liggitt iD, Dane A Grosvenor, Kimberly A Dill-McFarland iD, Matthew C Altman iD, Patrick J Concannon iD, Jane H Buckner iD und 2 weitere

Diabetes · 2025

DOI: 10.2337/db24-0655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Taylor K Watson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Immune Tolerance, Cytokines, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome-wide association studies have identified SH2B3 as an important non-MHC gene for islet autoimmunity and type 1 diabetes (T1D). In this study, we found a single SH2B3 haplotype significantly associated with increased risk for human T1D. Fine mapping has demonstrated the most credible causative variant is the single nucleotide rs3184504*T polymorphism in SH2B3. To better characterize the role of SH2B3 in T1D, we used mouse modeling and found a T-cell–intrinsic role for SH2B3 regulating peripheral tolerance. SH2B3 deficiency had minimal effect on T-cell receptor (TCR) signaling or proliferation across antigen doses, yet enhanced cell survival and cytokine signaling including common γ-chain–dependent and interferon-γ receptor signaling. SH2B3-deficient naive CD8+ T cells showed augmented STAT5-MYC and effector-related gene expression partially reversed with blocking autocrine IL-2 in culture. Using the rat insulin promoter–membrane-bound ovalbumin (RIP-mOVA) model, we found CD8+ T cells lacking SH2B3 promoted early islet destruction and diabetes without requiring CD4+ T cell help. SH2B3-deficient cells demonstrated increased survival and reduced activation-induced cell death. Lastly, we created a spontaneous NOD.Sh2b3−/− mouse model and found markedly increased incidence and accelerated T1D across sexes. Collectively, these studies identify SH2B3 as a critical mediator of peripheral T-cell tolerance limiting the T-cell response to self-antigens. Article Highlights The rs3184504*T polymorphism, encoding a hypomorphic variant of the negative regulator SH2B3, strongly associates with type 1 diabetes. SH2B3 deficiency results in hypersensitivity to cytokines, including IL-2 and IFN-γ, in murine CD4+ and CD8+ T cells, particularly postactivation. SH2B3-deficient CD8+ T cells exhibit a transcriptome comparable to wild-type CD8+ T cells at baseline, but, upon antigen stimulation, SH2B3-deficient cells upregulate genes characteristic of enhanced JAK-STAT signaling and effector functions. T-cell–intrinsic SH2B3 deficiency results in severe islet destruction in an adoptive transfer murine type 1 diabetes model, whereas global SH2B3 deficiency accelerates spontaneous NOD diabetes across sexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Immune ToleranceCytokinesCD8-Positive T-LymphocytesAnimalsMiceHumansSignal TransductionMice, Inbred NODFemalePolymorphism, Single NucleotideMaleIslets of LangerhansMice, KnockoutAdaptor Proteins, Signal Transducing

Substanzen

CytokinesSH2B3 protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.
  • Joint CMU-Pitt PhD Program in Computational Biology, Carnegie Mellon University and University of Pittsburgh, Pittsburgh, PA.
  • Center for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh, Pittsburgh, PA.
  • Genetics Institute and Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL.
  • International Center for Genetic Engineering and Biotechnology, China Regional Research Center, Taizhou, China.
  • Department of Comparative Medicine, University of Washington, Seattle, WA.

ORCID-Profile: Taylor K Watson, Aaron B I Rosen, Travis Drow, Jacob A Medjo, Yan Ge, H Denny Liggitt, Kimberly A Dill-McFarland, Matthew C Altman, Patrick J Concannon, Jane H Buckner, David J Rawlings, Eric J Allenspach

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Watson, T. K., Rosen, A. B. I., Drow, T., Medjo, J. A., MacQuivey, M. A., Ge, Y., Liggitt, H. D., Grosvenor, D. A., Dill-McFarland, K. A., Altman, M. C., Concannon, P. J., Buckner, J. H., Rawlings, D. J., & Allenspach, E. J. (2025). Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell–Intrinsic Immune Tolerance. Diabetes. https://doi.org/10.2337/db24-0655

Vancouver

Watson TK, Rosen ABI, Drow T, Medjo JA, MacQuivey MA, Ge Y, et al. Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell–Intrinsic Immune Tolerance. Diabetes. 2025. doi:10.2337/db24-0655

BibTeX
@article{Watson2025,
  author = {Watson, Taylor K and Rosen, Aaron B I and Drow, Travis and Medjo, Jacob A and MacQuivey, Matthew A and Ge, Yan and Liggitt, H Denny and Grosvenor, Dane A and Dill-McFarland, Kimberly A and Altman, Matthew C and Concannon, Patrick J and Buckner, Jane H and Rawlings, David J and Allenspach, Eric J},
  title = {Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell–Intrinsic Immune Tolerance},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-0655}
}
Kostenlos starten →